xmt-1001
Small moleculeexperimental
Clinical trial activity
1 trials · 11 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2011 (NCT00455052)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- xmt1001
- xmt 1001
- xmt-1001
- xmt-1001
- xmt-1001
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00455052 | Phase 1 | Mar 1, 2011 | Baylor University, Comprehensive Cancer Centers of Nevada, EvergreenHealth, Indiana University, Mersana Therapeutics, Northwest Cancer Specialists, P.C., Rocky Mountain Cancer Centers, TGen Drug Development, University of Maryland, Virginia Oncology Associates, Willamette Valley Cancer Institute |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (11)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Baylor University | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Comprehensive Cancer Centers of Nevada | Academic/Hospital | 1 | 0 | 1 | 2011 |
| EvergreenHealth | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Indiana University | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Mersana Therapeutics | For profit | 1 | 1 | 1 | 2011 |
| Northwest Cancer Specialists, P.C. | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Rocky Mountain Cancer Centers | Academic/Hospital | 1 | 0 | 1 | 2011 |
| TGen Drug Development | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of Maryland | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Virginia Oncology Associates | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Willamette Valley Cancer Institute | Academic/Hospital | 1 | 0 | 1 | 2011 |
11 organizations
Page 1 / 1